BREAKING
Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago Earnings Summary: Highlights of Calumet’s (CLMT) Q4 2025 earnings report 2 days ago Zoom Communications Q4 2025 Earnings Results 3 days ago Agilent Q1 Revenue Rises 7%, Net Income Declines 3 days ago Synopsys Q1 2026 Earnings Results 3 days ago Key highlights from J.M. Smucker’s (SJM) Q3 2026 earnings results 3 days ago Hormel Foods (HRL) Q1 2026 Earnings: Key financials and quarterly highlights 3 days ago Key metrics from Lowe’s (LOW) Q4 2025 earnings results 4 days ago Earnings Preview: Best Buy (BBY) expected to report lower earnings in Q4 2026 5 days ago Apple Inc. (AAPL) Surges 5.1% — Developing Story 5 days ago Mastercard Incorporated (MA) Drops 5.6% — Developing Story 5 days ago
ADVERTISEMENT
Market News

What to look for when CrowdStrike (CRWD) reports Q4 earnings

CrowdStrike Holdings Inc. (NASDAQ: CRWD) is scheduled to report fourth quarter 2020 earnings results on Thursday, March 19, after the market closes. The company is expected to report a loss of $0.08 per share on revenue of $137.7 million. The cybersecurity firm’s topline numbers are expected to benefit from strong growth in subscriptions. The increasing […]

$CRWD March 17, 2020 2 min read
NYSE
$CRWD · Earnings

CrowdStrike Holdings Inc. (NASDAQ: CRWD) is scheduled to report fourth quarter 2020 earnings results on Thursday, March 19, after the market closes. The company is expected to report a loss of $0.08 per share on revenue of $137.7 million. The cybersecurity firm’s topline numbers are expected to benefit from strong growth in subscriptions. The increasing […]

· March 17, 2020

CrowdStrike Holdings Inc. (NASDAQ: CRWD) is scheduled to
report fourth quarter 2020 earnings results on Thursday, March 19, after the
market closes. The company is expected to report a loss of $0.08 per share on
revenue of $137.7 million.

The cybersecurity firm’s topline numbers are expected to
benefit from strong growth in subscriptions. The increasing demand for security
solutions in the current environment will prove beneficial for the company. The
company’s highly flexible and easy-to-install platforms also gives it an edge
over its rivals in the space.

The expansion and demand for the Falcon platform is also
likely to drive growth in the to-be-reported quarter. However, CrowdStrike is
expected to incur higher expenses due to increasing investments in the cloud
security market. These expenses are likely to weigh on the bottom line results.

In the third quarter of 2020, CrowdStrike topped market
estimates with an 88% increase in total revenues and a narrower-than-expected adjusted
loss of $0.07 per share. Subscription revenue jumped 98% to
$114 million. The company added a record 772 net new subscription customers,
taking the total number of subscriptions customers to 4,561 at the end of the third
quarter.

For the fourth quarter of 2020,
CrowdStrike has guided for revenue of $135.9
million to $138.6 million. Adjusted net loss is
expected to be in the range of $19.1 million to $17.2 million, while adjusted loss
per share is estimated to be $0.09-0.08.

ADVERTISEMENT

For fiscal 2020, the company expects revenues of $465.2-468.0 million and an adjusted loss of $77.7-75.8 million. Full-year adjusted loss per share is expected to be between $0.53 and $0.52.

CrowdStrike’s shares have fallen 43% in the past one month. The stock was up 13% in afternoon hours on Tuesday.

ADVERTISEMENT